To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

Launched by JW PHARMACEUTICAL · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new medication called JW2286 to see how safe it is and how the body processes it after taking it by mouth. The trial will involve healthy adults who are either Korean or Caucasian. It is designed to gather important information about how the medication works, including how food might affect its absorption and if there are any differences based on ethnicity.

To be eligible for this study, participants must be healthy and not have any serious medical conditions or a history of gastrointestinal issues. Women who can become pregnant will also need to be surgically sterile to participate. Participants can expect to be randomly assigned to receive either the medication or a placebo (a non-active pill) in a controlled setting, where they will be closely monitored for any side effects. This study is currently recruiting volunteers aged 19 to 62, and it’s a great opportunity for those who meet the criteria to contribute to important medical research.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Healthy Korean or Caucasian volunteers
• Exclusion Criteria:
• • Individuals with a clinically significant disease or history
• • Individuals with a history of a gastrointestinal disorder or surgery
• • In the case of all female individuals with childbearing potential, except for those who are surgically sterile